Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
SNOAW was delisted on the 22nd of January, 2020.
0 hedge funds and large institutions have $0 invested in Sonoma Pharmaceuticals, Inc. Warrants in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1K | -95,541 | Closed |
|
SNOAW Hedge Fund Activity: Q4 2019 in Review
0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q4 2019, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SNOAW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $1K sold.
- 0 institutional investors held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q4 2019, down from 1 in Q3 2019.
- Funds reported $0 of Sonoma Pharmaceuticals, Inc. Warrants stock for Q4 2019, down 100% quarter-over-quarter.
- 0 funds opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q4 2019 and 1 closed out, a net change of -1 holder.
- The largest Sonoma Pharmaceuticals, Inc. Warrants seller in Q4 2019 was Susquehanna International Group, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2019.